CBMC Faculty Journal Club
3004 Marsico Hall
Loading view.
CBMC
CBMC Faculty Journal Club
3004 Marsico Hall
Jinan University Visit
4003 Fedex GlobalDr. Lee’s Natural Products Research Laboratories has a delegation of seven visitors coming from Jinan University in China for a symposium-style visit from October 16-17, 2017. They will meet with School administrators October 16 at 10:30 a.m. Dr. Lee was … Read more
NIH / NCATS Assay Guidance Workshop for High-Throughput Screening and Lead Discovery
Carolina ClubThe UNC Catalyst for Rare Diseases, together with Promega, is sponsoring an NIH / NCATS Assay Guidance Workshop for High-Throughput Screening and Lead Discovery on Monday, October 23, 2017. The workshop is being held from 8 a.m. to 6:30 p.m. … Read more
Catalyst Director Candidate Seminar
4004 Marsico HallSean Ekins, Ph.D., D.Sc. Candidate: Director, UNC Catalyst for Rare Diseases Co-founder & CEO of Phoenix Nest, Inc., and Founder & CEO of Collaborations Pharmaceuticals, Inc. “No Disease is Too Small: Leveraging NIH Funding to Start Rare- and Neglected-Disease … Read more
UNC Catalyst Director Candidate Seminar
G030 BondurantThe Division of Chemical Biology and Medicinal Chemistry presents a candidate for director of the UNC Catalyst for Rare Diseases. ANTHONY J. HICKEY, D.SC., PH.D. Distinguished RTI Fellow, Research Triangle Institute Professor Emeritus of Molecular Pharmaceutics, UNC Eshelman School … Read more
From Systems Biology to Systems Biologics
Kerr 2001Speaker: Sachdev Sidhu, PhD University of Toronto
Seminar: “Developing and using free energy calculations to guide pharmaceutical lead optimization”
Kerr 2001Special Seminar: Dr. David L. Mobley, UC Irvine Associate Professor Pharmaceutical Sciences, University of California, Irvine Abstract: I will give an overview of recent work in the group developing and applying computational tools for pharmaceutical drug discovery, with a … Read more
Gennady Poda, Ph.D. Seminar: “Structure-Based Design of Inhibitors of Bcl-6 and WDR5 Protein-Protein Interactions for the Treatment of Blood Cancers ”
“Structure-Based Design of Inhibitors of Bcl-6 and WDR5 Protein-Protein Interactions for the Treatment of Blood Cancers ” Friday, May 3, 2019 2:30-3:30 p.m. Beard Hall 116 Dr. Gennady Poda is an expert in computational drug discovery and a Scientific Advisor … Read more